Aktiia

Aktiia is a Swiss health-tech company founded in 2018 by Dr. Mattia Bertschi and Dr. Josep Solà, creating the world's first automated cuffless blood pressure monitor. Spun out of the Centre Suisse d'Electronique et de Microtechnique following 15 years of research, the company represents breakthrough medical technology. The Aktiia wristband uses proprietary Optical Blood Pressure Monitoring technology, leveraging optical sensors to continuously track blood pressure through photoplethysmography (PPG). This innovation allows users to monitor their cardiovascular health 24/7 without the discomfort and inconvenience of traditional cuff-based monitors. Aktiia received CE mark approval in 2021 for European sales and made history with FDA clearance as the first cuffless blood pressure monitor authorised for over-the-counter sale in the USA. The device is now approved in 44 countries and available in Switzerland, Germany, France, Austria, Italy, the UK, and Ireland. The company has raised significant funding including a $17.5M Series A led by Molten Ventures and CHF 27 million in subsequent rounds, demonstrating strong investor confidence in their mission to revolutionise blood pressure monitoring and improve cardiovascular health outcomes.